UNSW Research Web and Researcher Profiles are undergoing scheduled maintenance between 9:00 am on 9th October 2024 and 5:00 pm on 9th October 2024.
Content changes made during this period will be lost. This maintenance does not impact InfoEd or other applications.

Select Publications

Conference Papers

Emmett L; Joshua A; Epstein R; Chalasani V; Kneebone A; Hruby G; O'Neill G; Stricker P; Stricker P; Quoc N; Ho B, 2018, 'Modulation of PSMA expression by Androgen deprivation therapy (ADT): Serial PSMA PET in men with hormone sensitive, and castrate resistant prostate cancer commencing androgen blockade', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, PA, Philadelphia, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), PA, Philadelphia, 23 June 2018 - 26 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467489900093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Crumbaker M; Joshua AM; Epstein R; Emmett L, 2018, 'A phase I study of Lu-177-DKFZ PSMA 617 combined with the radiosensitizer idronoxil in men with metastatic castrate-resistant prostate cancer (mCRPC) (LuPin trial).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS5088

Sternberg CN; Saad F; Graff JN; Peer A; Vaishampayan UN; Leung E; Rosenbaum E; Gurney H; Epstein R; Davis ID; Wu B; Trandafir L; Wagner VJ; Hussain M, 2018, 'A randomized phase 2 study investigating 3 dosing regimens of radium-223 dichloride (Ra-223) in bone metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.5008

Yau T; Wong H; Lau S; Leung R; Chiu J; Wong TT; Liang R; Epstein RJ; Cheung P, 2012, 'Comparison of Clinicopathologic Features of Invasive Lobular Carcinoma of the Breast with or Without Associated Lobular Carcinoma In-situ', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, pp. S179 - S179, presented at 8th European Breast Cancer Conference (EBCC), AUSTRIA, Vienna, 21 March 2012 - 24 March 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302804600460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong H; Lau S; Cheung P; Leung R; Chiu J; Wong TT; Liang R; Epstein RJ; Yau T, 2012, 'Ki67 Proliferation Index in Invasive Lobular Carcinoma of the Breast - Clinicopathologic Correlation and Prognostic Significance', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, pp. S136 - S136, presented at 8th European Breast Cancer Conference (EBCC), AUSTRIA, Vienna, 21 March 2012 - 24 March 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302804600328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Epstein RJ, 2010, 'INFLUENCE OF INCOME AND EDUCATION ON ANTICANCER DRUG PURCHASING DECISIONS IN HONG KONG CHINESE CANCER PATIENTS', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, ITALY, Milan, pp. 369 - 369, presented at 35th European-Society-for-Medical-Oncology (ESMO) Congress, ITALY, Milan, 08 October 2010 - 12 October 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284592300406&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yau T; Chan P; Wong H; Ng KK; Chok SH; Cheung TT; Lam V; Epstein RJ; Fan ST; Poon RTP, 2007, 'Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma', in Oncology, pp. 67 - 71, http://dx.doi.org/10.1159/000111709


Back to profile page